Abstract:Background: Asthma is a chronic inflammatory disease characterized by airway inflammation and airway hyperresponsiveness (AHR). IL-33 is considered as one of the most critical molecules in asthma pathogenesis. IL-33 is stored in nucleus and passively released during necrosis. But little is known about whether living cells can release IL-33 and how this process is regulated. Objective: We sought to investigate the role of polymerase I and transcript release factor (PTRF) in IL-33 release and asthma pathogenesis. Methods: Ovalbumin (OVA)-induced asthma model in PTRF+/- mice were employed to dissect the role of PTRF in vivo. Then, further in vitro experiments were carried out to unwind the potential mechanism involved. Results: In OVA asthma model with challenge phase, PTRF+/- mice showed a greater airway hyper-reaction, with an intense airway inflammation and more eosinophils in bronchoalveolar lavage fluid (BALF). Consistently, more acute type 2 immune response in lung and a higher IL-33 level in BALF were found in PTRF+/- mice. In OVA asthma model without challenge phase, airway inflammation and local type 2 immune responses were comparable between control mice and PTRF+/- mice. Knockdown of PTRF in 16HBE led to a significantly increased level of IL-33 in cell culture supernatants in response to LPS or HDM. Immunoprecipitation assay clarified Y158 as the major phosphorylation site of PTRF, which was also critical for the interaction of IL-33 and PTRF. Overexpression of dephosphorylated mutant Y158F of PTRF sequestered IL-33 in nucleus together with PTRF and limited IL-33 extracellular secretion. Conclusion: Partial loss of PTRF led to a greater AHR and potent type 2 immune responses during challenge phase of asthma model, without influencing the sensitization phase. PTRF phosphorylation status determined subcellular location of PTRF and, therefore, regulated IL-33 release.

PTRF-IL33-ZBP1 signaling mediating macrophage necroptosis contributes to HDM-induced airway inflammation

Dephosphorylated Polymerase I and Transcript Release Factor Prevents Allergic Asthma Exacerbations by Limiting IL-33 Release.

TRPC1 Intensifies House Dust Mite-Induced Airway Remodeling by Facilitating Epithelial-to-mesenchymal Transition and STAT3/NF-κB Signaling.

Peptidoglycan Recognition Protein 1 Promotes House Dust Mite-Induced Airway Inflammation in Mice

Inhibition of the Inflammasome Activity of NLRP3 Attenuates HDM-Induced Allergic Asthma

Caspase-1 activation by NLRP3 inflammasome dampens IL-33-dependent house dust mite-induced allergic lung inflammation.

TRIM47 promotes HDM‐induced bronchial epithelial pyroptosis by regulating NEMO ubiquitination to activate NF‐κB/NLRP3 signaling

IL-4Rα signaling in CD4+CD25+FoxP3+ T regulatory cells restrains airway inflammation via limiting local tissue IL-33

IL-33 amplifies airways inflammation in a murine surrogate of asthma possibly through acting on dendritic cells

Heme oxygenase-1 alleviates allergic airway inflammation by suppressing NF-κB-mediated pyroptosis of bronchial epithelial cells

RNA-Binding Protein HuR Promotes Airway Inflammation in a House Dust Mite-Induced Allergic Asthma Model

RAGE mediates airway inflammation via the HDAC1 pathway in a toluene diisocyanate-induced murine asthma model

Endoplasmic reticulum stress drives macrophages to produce IL-33 to favor Th2 polarization in the airways

DEK deficiency suppresses mitophagy to protect against house dust mite-induced asthma

House dust mite exposure upregulates C3a receptor expression in pulmonary innate immune cells during the sensitization phase of allergic asthma by an IL-33-dependent mechanism

House Dust Mite Regulate the Lung Inflammation of Asthmatic Mice Through TLR4 Pathway in Airway Epithelial Cells

The Transcription Factor PU.1 Promotes Alternative Macrophage Polarization and Asthmatic Airway Inflammation

Small Proline-Rich Protein 3 Regulates IL-33/ILC2 Axis to Promote Allergic Airway Inflammation

ATP/P2X7-NLRP3 Axis of Dendritic Cells Participates in the Regulation of Airway Inflammation and Hyper-Responsiveness in Asthma by Mediating HMGB1 Expression and Secretion.

Sphk1 regulates HMGB1 via HDAC4 and mediates epithelial pyroptosis in allergic rhinitis

NOD1 mediated D. pteronyssinus-induced allergic airway inflammation through RIP2/NF-κB